Swollen lymph nodes
Painless lumps in the neck, underarm or groin that persist or grow over time.
Cancer in the lymph nodes is either a lymphoma — a primary cancer of the lymphatic system — or metastatic disease that has spread from elsewhere. Lymphomas are the third most common cancer among young adults and children in Singapore, and radiotherapy retains an enduring, evidence-based role in their cure.
Cancer cells can break away from a primary tumour and travel through the lymphatic system, settling in lymph nodes — usually those nearest the original tumour. This is metastatic (secondary) lymph node cancer, and its treatment follows from the primary cancer's type.
Lymphomas are different: primary cancers of the lymphatic system itself, beginning when white blood cells (lymphocytes) develop mutations that let them multiply uncontrollably and escape normal cell death. Beyond the nodes, lymphoma can involve the thymus, spleen, bone marrow and other organs.
The two main families are Hodgkin's lymphoma — more common in young adults aged 15 to 30 — and non-Hodgkin's lymphoma, which is more common overall and in older people, including diffuse large B-cell and follicular lymphomas. Treatment and prognosis depend on the exact type, which is why expert pathology comes first.
A painless, persistent lump is the classic sign — though enlarged nodes have many non-cancer causes. See a doctor for:
Painless lumps in the neck, underarm or groin that persist or grow over time.
Persistent or recurring fevers without infection.
Drenching night sweats.
Tiredness that doesn't improve with rest.
Unexplained weight loss or loss of appetite.
Shortness of breath, chest pain, or unexplained abdominal or bone pain.
Because treatment differs completely between lymphoma types — and between lymphoma and metastasis — diagnosis rests on expert tissue analysis.
Examination of all node regions, plus blood tests including full blood count and markers.
A whole node (or generous core) gives pathology enough tissue to type the lymphoma precisely.
Whole-body PET-CT maps every involved site — the foundation of lymphoma staging and response assessment.
Where indicated, marrow sampling completes the stage.
Most lymphomas arise without a clear cause — but immunity plays a central role:
Immune suppression from birth, from immunosuppressant drugs, or from HIV infection raises lymphoma risk.
Hodgkin's lymphoma peaks in young adults (15–30); non-Hodgkin's becomes more common with age.
EBV and certain chronic infections are associated with specific lymphoma types.
Some autoimmune conditions and their treatments raise risk.
A modest increase in risk with affected first-degree relatives.
For secondary nodal disease, the main risk factor is simply the primary cancer itself.
Systemic therapy leads most lymphoma treatment — with radiotherapy playing an enduring, precisely defined role, and SBRT offering options for limited metastatic nodal disease.
Modern lymphoma radiation treats only the involved sites at modest doses — consolidating cure after chemotherapy with far less exposure than historical fields.
Radiation sequenced with the chemotherapy and immunotherapy regimens that anchor lymphoma cure.
For limited metastatic nodal disease from solid cancers — precise ablative treatment of each involved node.
Fast, gentle relief of symptomatic nodal masses where the goal is comfort.
Every plan at AARO goes through detailed contouring, dose simulation, and independent physics review before a single beam is delivered. We do this so the radiation hits exactly the tissue that needs it — and avoids the healthy tissue around it.
Our medical physicists and radiation therapists collaborate on each plan — contouring tumour and organs-at-risk, simulating dose distribution, and independently checking every parameter before delivery.
Imaging before each fraction confirms the target's position to the millimetre — so tight margins stay safe, and healthy tissue stays out of the high-dose region.
Each treatment session takes 15–30 minutes. You'll lie on a precision treatment couch beneath the linear accelerator. Positioning lasers and daily imaging align you to within a millimetre of the planned position.
You won't feel the radiation as it's delivered. There's no anaesthesia, no recovery time, and no overnight stay. Most patients drive themselves home after the session and return to normal activities the same day.
Lymphoma radiotherapy at AARO is planned with your haematologist — with sub-specialist expertise in haemato-oncology and modern involved-site techniques.
Book a 45–60 minute specialist consultation. We'll review your imaging and pathology, explain the options that apply to your case, and answer your questions.